Ten post jest także dostępny w języku: polski
According to a report by PMR and Upper Finance Group, the surgical robotics market in Poland will grow from PLN 92m to nearly PLN 500m between 2019 and 2023, which means that the average annual growth in value (CAGR) of this segment will be as high as 50%. This value includes not only the total amount of sales of robots – additionally, the purchase of instruments and disposable materials needed to perform the procedure, services, as well as the value of medical services themselves are included.
The market will exceed PLN 450m in 2023
Such a high dynamics results not only from the trend of purchasing new instruments by individuals in Poland, but also from the increase in efficiency and applications per instrument. We estimate that the effectiveness of the instruments will increase at least twice in the analysed period. This is related, among others, to the growing awareness of this technology among specialists and patients.
The manufacturer himself is also constantly improving and developing this tool. Fast growth is also the result of low market penetration. For example, in the United States, robotics surgery has up to 98% penetration in urological procedures – in Poland, despite the obvious benefits, this range is still small.
Will there be financing of robot surgery by the NFZ?
It is worth noting that the market dynamics would be even higher if a separate programme of financing these procedures by the NFZ was introduced. The Ministry of Health announced such changes, however, at the time of drafting the current report, the moment of realization of these promises was difficult to predict. We expect, however, that such a move is inevitable due to the benefits that this method offers.
The survey, carried out by PMR and Upper Finance, was conducted among representatives of institutions working with authorised robot systems, i.e. in the Wojewódzki Szpital Specjalistyczny in Wroclaw, NZOZ Szpital Mazovia – Specjalistyczny Szpital Urologiczny, Wojewodzkie Centrum Onkologii in Poznan, Szpital Medicover in Warsaw, Szpital na Klinach in Krakow and in the Mazowiecki Szpital Wojewodzki in Siedlce.